CUR Key Statistics, Chart & Performance
The current stock price of CUR is 1.52 null. In the past month the price increased by 4.83%. In the past year, price decreased by -86.43%.
About CUR
Company Profile
NEURALSTEM's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.
Company Info
NEURALSTEM INC
20271 Goldenrod Lane
Germantown MD 20876
CEO: Kenneth Carter
Phone: 301-366-4841
NEURALSTEM INC / CUR FAQ
What does CUR do?
NEURALSTEM's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug application will be for the treatment of Ischemic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment.
What is the stock price of NEURALSTEM INC today?
The current stock price of CUR is 1.52 null. The price decreased by -16.94% in the last trading session.
Does CUR stock pay dividends?
CUR does not pay a dividend.
How is the ChartMill rating for NEURALSTEM INC?
CUR has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
Can you provide the ownership details for CUR stock?
You can find the ownership structure of NEURALSTEM INC (CUR) on the Ownership tab.
CUR Technical Analysis
ChartMill assigns a technical rating of 1 / 10 to CUR. When comparing the yearly performance of all stocks, CUR is a bad performer in the overall market: 97.87% of all stocks are doing better.
CUR Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to CUR. CUR has a bad profitability rating. Also its financial health evaluation is rather negative.
CUR Financial Highlights
Over the last trailing twelve months CUR reported a non-GAAP Earnings per Share(EPS) of -5.37. The EPS decreased by -858.93% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -43516.23% | ||
| ROA | -190.29% | ||
| ROE | N/A | ||
| Debt/Equity | 0 |